Sort
82,697 grants matching “vaccine development”
Modeling affinity maturation at molecular resolution
$1,900,400Thomas B Kepler · Boston University Medical Campus · U19 · FY2019 · AI
RFA-IP-22-004, Platform to Assess Influenza and COVID-19 Vaccine Effectiveness in Underserved Arizona Populations
$1,900,000Vel Murugan · Arizona State University-Tempe Campus · U01 · FY2023 · IP
RFA-IP-22-004, Evaluating respiratory virus vaccine effectiveness in a large, diverse healthcare system
$1,900,000Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · IP
SPORE in Lung Cancer
$1,900,000Eric B. Haura · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2011 · CA
Flavivirus Infections: Pathogenesis and Prevention
$1,900,000Alan L Rothman · University Of Rhode Island · P01 · FY2018 · AI
Center for Research on Processes in Evolution
$1,899,823Larry J Forney · University Of Idaho · P20 · FY2012 · GM
Natural History of HPV Infection in Men: The HIM Study
$1,899,816Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
A-Z Clinical Trials Unit
$1,899,800Paul A. Goepfert · University Of Alabama At Birmingham · UM1 · FY2022 · AI
Protein homeostasis mechanisms underlying enterovirus replication and evolution
$1,898,481Raul Andino · University Of California, San Francisco · P01 · FY2014 · AI
In Situ Tumor Vaccination with a Nano-oligo Therapeutic to Induce Whole-body Antitumor Immune Response
$1,898,361Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2021 · CA
Structure-Based Antagonism of HIV-1 Envelope Function in Cell Entry
$1,898,052Irwin M Chaiken · Drexel University · P01 · FY2022 · AI
Activation of Plasmacytoid Dendritic Cells (pDCs) to Induce Antitumor Activity
$1,898,043Patrick Hwu · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Clonal Dynamics of HIV/SIV-specific T cells
$1,897,692Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Cellular Immunity to Category A-C Viruses in Humans
$1,897,411Univ Of Massachusetts Med Sch Worcester · U19 · FY2003 · AI
DNA Vaccines
$1,897,092George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Kaiser Washington Vaccine and Treatment Evaluation Unit
$1,896,679Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2021 · AI
BASE AWARD
$1,896,671Gregory Sorenson · University Of Maryland Baltimore County · N01 · FY2023 · AI
Preclinical Studies of Vaccines for Pandemic Influenza
$1,896,554Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Colorado AIDS Clinical Trials Unit
$1,896,461Thomas B. Campbell · University Of Colorado Denver · U01 · FY2011 · AI
Shaping Antiviral Immunity by the Inflammatory, Regulatory and Tissue Environment
$1,896,120E. John Wherry · University Of Pennsylvania · U19 · FY2013 · AI
Flavivirus Infections: Pathogenesis and Prevention
$1,896,069Alan L Rothman · University Of Rhode Island · P01 · FY2021 · AI
Flavivirus Infections: Pathogenesis and Prevention
$1,896,069Alan L Rothman · University Of Rhode Island · P01 · FY2022 · AI
Clinical Research Support for the CCR
$1,895,729Robert Wiltrout · Division Of Basic Sciences - Nci · ZID · FY2011 · CA
University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
$1,895,589Carl J Fichtenbaum · University Of Cincinnati · U01 · FY2009 · AI
Multi-component HIV Vaccines Using Engineered Envelopes
$1,894,091Novartis Vaccines And Diagnostics, Inc. · P01 · FY2002 · AI